PRINCETON, N.J., Oct. 17, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery ...
The use of a nonselective extracorporeal blood purification device connected to the cardiopulmonary bypass circuit in a nonemergent population of patients undergoing cardiac surgery was associated ...
This simplifies purification procedures ... as well as magnetic isolation of protein complexes from cell lysates or blood which have binding activity for the recombinant protein sitting on ...
AFERsmart is an integrated unit to perform blood purification treatments like Plasma Exchange, Double Filtration, Selective Double Filtration, Double Filtration with Adsorption and Hemoperfusion.
For patients undergoing nonemergent cardiopulmonary bypass (CPB), use of an extracorporeal blood purification (EBP) device is associated with a lower rate of cardiac surgery-associated acute ...